Mallinckrodt Pharmaceuticals · 2 months ago
Head of Investor Relations
Bridgewater, NJ
Full-time
Onsite
Director/Executive
$330K/yr - $430K/yr
12+ years expMallinckrodt Pharmaceuticals is seeking a Head of Investor Relations who will be responsible for creating and executing the Company’s IR strategy and communication materials. The role involves developing relationships with institutional investors and collaborating with various teams to ensure effective messaging.
Biotechnology
Responsibilities
Leads investor relations strategic initiatives and activities to ensure alignment and understanding of the company’s strategic messages and enhance the company’s reputation
Serves as a trusted spokesperson and point of contact for investors, analysts, and the financial community
Leads strategic development of key messages, Q&As, publications, presentations, and electronic media (i.e. IR website) used in the IR program. Performs the data collection, analysis, writing, editing, and production of those materials in collaboration with Leadership and other functions
Monitors investor sentiment, shareholder composition, and market trends to advise senior leadership and the Board
Leads and manages ongoing and productive dialogue with analysts and investors (traditional & CR&S) to promote a better understanding of the company’s value proposition, financial goals and growth strategies. This includes investor outreach, targeting, and relationship management, including IR conferences and roadshows, investor tours, and meetings/conference calls
Provides management an understanding of external perspectives on the company as well as ownership information and buying/selling trends. This includes but is not limited to active monitoring of security analysts’ research and earnings estimates, consensus models, relative stock price movements, and periodic ownership analysis and supports the monitoring of trading data
Collaborate with Corporate Communications, ESG, and Strategy teams to integrate company narrative into investor messaging
Lead the preparation and delivery of quarterly earnings announcements, investor calls, and financial reporting materials
Oversee the creation of investor presentations, press releases, and other communication tools to ensure clarity, accuracy, and compliance
Partner with Finance and Legal to ensure all external communications meet regulatory and disclosure requirements
Provide insights to leadership on market perception, competitive landscape, and valuation drivers
Participates in crisis communication preparedness initiatives, including data collection and analysis, drafting, editing, and support
Provides leadership and coaching to maintain a “best-in-class” function
Lead by example in areas of change management and be able to think creatively about talent development and organizational structure
Qualification
Required
Bachelor's degree required; MBA preferred
Requires a minimum of 12+ years of progressive experience in investor relations, corporate finance, investment banking, or equity research within a public company
Prior pharmaceutical/biotech experience is required
Strong understanding of financial statements, valuation methodologies, and capital markets dynamics
Must have demonstrated leadership experience
A solid understanding of finance, strategic communication, and trends, public relations, marketing, advertising, and the media
Must demonstrate good judgment, exceptional writing, analytical, presentation preparation, and project management skills
Outstanding financial and investment analysis skills, oral and written communication skills, and presentation ability
Strategic thinker with strong financial acumen
An in-depth understanding of the financial and investment markets and the ability to adapt quickly to changes
Ability to simplify complex financial information for diverse audiences
Strong interpersonal skills and an outstanding ability to communicate using these qualities and skills
Skilled in storytelling and shaping compelling narratives
Strong leadership presence with the ability to interact at the executive and board level
Resilient, adaptable, and comfortable working in a fast-paced, dynamic environment across multiple functions in the organization
High level of integrity, discretion, and judgment
Travel and working across time-zones required
Preferred
MBA preferred
Additional experience in corporate or brand communications, marketing, or planning/development preferred
Benefits
This position is eligible for a bonus in accordance with the terms of the applicable program.
Bonuses are awarded at the Company’s discretion.
Company
Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
unknown2013-07-01IPO
Leadership Team
Paul O'Neill
SVP Quality and Operations, Specialty Brands
Recent News
2025-11-12
Company data provided by crunchbase